首页> 外文OA文献 >The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog

【2h】

The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog

机译：马来酸盐马来酸盐（一种Janus激酶抑制剂）在狗体内的药代动力学

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
W. T. Collard; B. D. Hummel; A. F. Fielder; V. L. King; J. F. Boucher; M. A. Mullins; P. B. Malpas; M. R. Stegemann;
展开▼
作者单位

展开▼
年度 2013
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog. [J] . Collard W. T., Hummel B. D., Fielder A. F., Journal of Veterinary Pharmacology and Therapeutics . 2014,第3期

机译：马来酸oclacitinib（一种Janus激酶抑制剂）在狗中的药代动力学。
2. Oclacitinib, a novel Janus kinase inhibitor for the treatment of atopic dermatitis and other case of pruritus in dogs [J] . Akos Jerzsele, Dora Kovacs, Zoltan Somogyi Magyar Allatorvosok Lapja . 2017,第9期

机译：Oclacitinib，一种新的Janus激酶抑制剂，用于治疗特应性皮炎和狗瘙痒的其他情况
3. A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel (R)) in client-owned dogs with atopic dermatitis [J] . Cosgrove Sallie B., Wren Jody A., Cleaver Dawn M., Veterinary Dermatology . 2013,第6期

机译：Janus激酶抑制剂oclacitinib（Apoquel（R））在特应性皮炎的客户拥有的狗中的功效和安全性的双盲，随机，安慰剂对照试验
4. USING TYROSINE KINASE INHIBITORS AND METRONOMIC CHEMOTHERAPY TO IMPROVE ANTITUMORIMMUNITY IN DOGS [C] . Barb Biller Conference of the American College of Veterinary Internal Medicine . 2014

机译：使用酪氨酸激酶抑制剂和衡量化疗，从而改善狗的抗肿瘤
5. Synthesis of Small Molecule Inhibitors of Janus Kinase 2, Phosphodiesterase IV, GABAA and NMDA receptors: Investigation of Mcmurry, Mannich and Chemoenzymatic Strategies [D] . Gali, Meghanath 2011

机译：Janus激酶2，磷酸二酯酶IV，GABAA和NMDA受体的小分子抑制剂的合成：Mcmurry，Mannich和化学酶策略的研究
6. A blinded randomized placebo‐controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client‐owned dogs with atopic dermatitis [O] . Sallie B. Cosgrove, *, Jody A. Wren, -1

机译：Janus激酶抑制剂oclacitinib（Apoquel®）在患有特应性皮炎的客户拥有的狗中的功效和安全性的双盲随机安慰剂对照试验
7. Janus kinase (Jak) subcellular localization revisited: the exclusive membrane localization of endogenous Janus kinase 1 by cytokine receptor interaction uncovers the Jak.receptor complex to be equivalent to a receptor tyrosine kinase [O] . Behrmann, Iris, Smyczek, Tanja, Heinrich, Peter C., 2004

机译：重新审查Janus激酶（Jak）亚细胞定位：通过细胞因子受体相互作用对内源性Janus激酶1的独家膜定位揭示了Jak.receptor复合物等同于受体酪氨酸激酶

The pharmacokinetics of oclacitinib maleate, a Janus kinase inhibitor, in the dog

著录项

引文网络

相似文献

相关主题

期刊订阅